Amplia Therapeutics Limited

ASX:ATX Stock Report

Market Cap: AU$61.6m

Amplia Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

ASX:ATX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
01 Sep 25BuyAU$30,000Jane BellIndividual130,435AU$0.23
01 Sep 25BuyAU$35,000Warwick TongIndividual152,174AU$0.23
01 Sep 25BuyAU$150,000Robert PeachIndividual652,174AU$0.23
01 Sep 25BuyAU$20,000Christopher BurnsIndividual86,957AU$0.23
29 Jul 25BuyAU$1,999,992Platinum Investment Management LimitedCompany8,695,653AU$0.23
29 Jul 25BuyAU$100,000Allan MossIndividual434,783AU$0.23
16 Jul 25SellAU$969,915Platinum Investment Management LimitedCompany3,699,915AU$0.36
19 Jun 25BuyAU$168,451Acorn Capital LimitedCompany1,070,625AU$0.16
18 Jun 25BuyAU$362,711Acorn Capital LimitedCompany5,059,812AU$0.079
15 May 25SellAU$752,866Platinum Investment Management LimitedCompany10,865,129AU$0.069
20 Dec 24BuyAU$79,999Jane BellIndividual695,652AU$0.11
20 Dec 24BuyAU$124,999Robert PeachIndividual1,086,957AU$0.11
20 Dec 24BuyAU$40,000Christopher BurnsIndividual347,826AU$0.11
20 Dec 24BuyAU$79,999Warwick TongIndividual695,652AU$0.11
25 Nov 24BuyAU$1,274,818Acorn Capital LimitedCompany11,330,840AU$0.12
15 Nov 24SellAU$413,845Acorn Capital LimitedCompany3,522,893AU$0.15

Insider Trading Volume

Insider Buying: ATX insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ATX?
Owner TypeNumber of SharesOwnership Percentage
Private Companies29,293,5195.71%
Hedge Funds45,313,9328.83%
Individual Insiders62,415,68312.2%
Institutions64,844,40912.6%
General Public311,204,08660.7%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 86.7%.

Top Shareholders

Top 24 shareholders own 39.34% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
8.83%
Platinum Investment Management Limited
45,313,932AU$5.4m12.4%0.14%
7.04%
Acorn Capital Limited
36,144,321AU$4.3m4.54%6.53%
3.93%
Allan Moss
20,165,845AU$2.4m2.2%no data
2.96%
Pengana Capital Group Limited
15,200,044AU$1.8m0%3.61%
2.63%
Pengana Capital Ltd.
13,500,044AU$1.6m0%4.43%
1.46%
Mishtalem Pty Ltd
7,500,000AU$900.0k0%no data
1.2%
Heh Enterprises Pty
6,150,000AU$738.0k0%no data
1.19%
Robert Peach
6,131,164AU$735.7k11.9%no data
1.1%
Christian Behrenbruch
5,642,738AU$677.1k15.5%no data
0.92%
Warwick Tong
4,710,280AU$565.2k26.9%no data
0.85%
James Simpson
4,347,826AU$521.7k0%no data
0.81%
Christopher Burns
4,155,574AU$498.7k2.14%no data
0.77%
Ctx Crc Ltd
3,940,579AU$472.9k0%no data
0.71%
Jane Bell
3,661,750AU$439.4k3.69%no data
0.6%
Heh Entreprises Pty Ltd
3,102,500AU$372.3k0%no data
0.58%
Robert Greenslade
3,000,000AU$360.0k24.4%no data
0.58%
J&J Stuart Pty Ltd
3,000,000AU$360.0k11.1%no data
0.58%
Dinwoodie Investments Pty Ltd
2,974,335AU$356.9k0%no data
0.55%
Anthony Martin
2,820,323AU$338.4k0%no data
0.51%
Ravinna Pty Ltd
2,626,105AU$315.1k0%no data
0.47%
Sharon Lewis
2,430,000AU$291.6k0%no data
0.43%
Nicholas McDonald
2,216,673AU$266.0k0%no data
0.31%
Michael Whiting
1,566,755AU$188.0k1.62%no data
0.31%
Tracey Whiting
1,566,755AU$188.0k1.62%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/06 20:45
End of Day Share Price 2025/11/06 00:00
Earnings2025/03/31
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Amplia Therapeutics Limited is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Thomas WakimBell Potter